Cannabis extract shows promise for Hard-to-Treat seizures in rare disease
NCT ID NCT07403266
First seen Feb 11, 2026 · Last updated May 22, 2026 · Updated 12 times
Summary
This study tests a full-spectrum cannabis extract called YCJ-01 in people with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard treatments. The goal is to see if it can reduce the number of seizures and is safe. The trial includes 84 participants aged 2 to 65.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBEROUS SCLEROSIS COMPLEX (TSC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Ruber Internacional
RECRUITINGMadrid, 28034, Spain
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.